Isolation and purification of copeptin hormone from serum of patients with heart disease
Article Sidebar
Main Article Content
Abstract
This study included isolation and purification of copepin hormone from heart disease patients serum using different biochemical techniques. The study showed two proteinous peak has been isolated by gel filtration (Sephadex G-50) from the precipitation by cold acetone, the results predicted that (peak B) has a high concentration of copepin . Furthermore, the purity of the isolated copeptin ( peak B) had been identified by SDS-poly acryl amide gel electrophoresis and the reverse phase high performance liquid chromatography in which results showed agood identity in retention time between the standard and the isolated copeptin (peak B) .
The approximate molecular weight of partially purified copeptin peak (B) was (4654±400 Dalton , ±4513400 Dalton) using gel filtration chromatography (Sephadex G-50) and (SDS-poly acryl amide gel electrophoresis) technique respectively .
The study of secondary structure (α-helix) to copeptin hormone by the (Circular Dichroesim) showed the percentage of the (α-helix) between the standard solution of copeptin and sample solution (peak B) was good match.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Holwerda, D.A(1972) “A glycopeptide from the posterior lobe of pig pituitaries characterization”. Eur J Biochem.;28: 334–339.. 2. Brunton, L.; Chabner, B. and Knollman, B. (2011)” editors. Goodman and Gilamn’s the pharmacological basis of therapeutics. 12th ed. China: McGrow-Hill companies. 3. Hammarsten, O. and Goetze, P.J.(2012)” Copeptin: A new peptide in clinical measurement”. Kilnisk Niokemi I Norden. 1:22-29. 4. Morgenthaler, N.G.; Struck, J.; Alonso, C. and Bergmann, A.(2006)” Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin”. Clin. Chem. 52(1):112-119. 5. Morgenthaler ,N.G.(2010)” Copeptin: A biomarker of cardiovascular and renal function”. Congest Heart Fail.16(4)(suppl 1):S37-S44. 6. Hanoune, J.(2010)” The neurohypophyseal system: synthesis and metabolism of vasopressin”. In: Laycock, J. F. “Perspectives on vasopressin”. London: Imperical college press. 7. Morgenthaler, N.G.; Muller, B.; Struck, J.; Bergmann , A.; Redl , H. and ChristCrain, M.(2007)” Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock”. Shock. 28(2):219–26. 8. Yalta , K.; Yalta, T.; Sirvi, N. and Yetkin, E. (2013)” Copeptin and cardiovascular disease: A review of a novel neurohormone”. Inter. J .Cardiol. 167(5):1750-1759. 9. Keller, T.; Tzikas, S.; Zeller, T.; Czyz, E.; Lillpopp, L.; Ojeda, FM.; Roth, A.; Bickel, C.; Baldus, S.; Sinning ,CR.; Wild, PS.; Lubos, E.; Peetz, D.; Kunde, J.; Hartmann, O.; Bergmann, A.; Post, F.; Lackner, KJ.; Genth-Zotz, S.; Nicaud ,V.; Tiret, L.; Münzel, TF. and Blankenberg, S. (2010)” Copeptin Improves Early Diagnosis of Acute Myocardial Infarction “J Am Coll Cardiol. 55 (19),:2096–2106 10. Schacterle, G.R. and Pollack, R. L. (1973).” A simplified method for the quantitatiue assay of small amounts of protein biological material”. Anal. Biochem. 51(2): 654-655. 11. Robyt , F.J. and White, J.B.(1987)” Biochemical techniques: theory and practice” Book Cole publishing Co.,USA.,141,235-236,246,263,269 12. Plummer,T.D.(1978)”An introduction of partical biochemistry” 2nd ed.,McGraw-Hill Book; Co. V.K., 48, 52,174,270,274. 13. Laemmli, U.K. (1970). “Cleavage of structural proteins during the assembly of the head of bacteriophage T4”. Nature. 227(5259):680-685. 14. Uysal, M.A. ; Bekar, N.; Demirer, E.; Sancak, M. and Yılmaz, V. (2013)” Serum Copeptin Levels and its Relation with Other Inflammatory Markers in Acute Exacerbation of COPD” J Ann Eu Med ;1(3): 56-61 15. Lowery, O.H.; Rosebrough, N.J.; Farr, A.L. and Randall, R.J. (1951). “Protein measurement with folin-phenol agent”. J. Biol. Chem. 193(1): 265-275. 16. Holme, D.J. and Peck, H. (1988). “Analytical Biochemistry”. John Wiley and Sons. Inc., New York, 86. 17. Maisel, A.; Mueller, C.; Neath, SX.; Christenson, RH.; Morgenthaler, NG.; McCord, J.; Nowak ,RM.; Vilke, G.; Daniels, LB.; Hollander, JE.; Apple, FS.; Cannon, C.; Nagurney, JT.; Schreiber, D.; deFilippi, C.; Hogan, C.; Diercks, DB.; Stein, JC.; Headden, G.; Limkakeng, AT.; Jr, Anand, I.; Wu AH, Papassotiriou ,J.; Hartmann, O.; Ebmeyer, S.; Clopton, P.; Jaffe, AS. and Peacock, WF.( 2013)” Copeptin Helps in the Early Detection of Patients With Acute Myocardial Infarction” JACC. 62 (2):151-160 18. Mastropietro ,W.C.; Mahan ,M.; Valentine, M.K.; Clark, A.J.; Hines, C.P. ;Walters, L.H.; Delius, RE.; Sarnaik, AP. and Rossi, NF.(2012)” Copeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery”. Intensive Care Med.38(12):2047-2054. 19. Okubo, T.; Suzuki, T.; Yokoyama, Y.; Kano, K. and Kano, I. (2003). “Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro”. Biol. Pharm. Bull., 26(8): 1219-1224. 20. Ferguson, K.K.; Cantonwine, D.E.; Rivera-González, L.O.; Loch-Caruso, R.; Mukherjee, B.; Anzalota Del Toro, L.V.; Jiménez-Vélez, B.; Calafat, A.M.; Ye, X.; Alshawabkeh, A.N.; Cordero, J.F.; Meeker, J.D.(2014)” Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico”. Environ. Sci. Technol.48(12):7018-7025
21. Kutzman , RS.; Meyer, G-J. and Wolf, AP. (1980)” Biodistribution and excretion of [11C]benzaldehyde by the rat after two-minute inhalation exposures”. Xenobiotica., 10(4): 281–288
22. Fiedler, N.;Laumbach,R.;Kelly-McNeil,K.; Lioy, P.; Fan, Z-H.; Zhang, J.; Ottenweller, J.; Ohman-Strickland,P. and Kipen,H.(2005)” Health Effects of a Mixture of Indoor Air Volatile Organics, Their Ozone Oxidation Products, and Stress” Environmental Health Perspectives ,.113(11):1542-1548